Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
72
datasets available to search
ShareScore release 0.9.0
Dataset results
72 results for “silymarin”
Figure 2 in Investigation of the effect of silymarin on oxidative DNA damage and inflammatory markers in ischemia/reperfusion injury following experimental testicular torsion/detorsion in rats
Figure 2. Testicular tissue, control group, negative Tnf-α expression (A). T 3 h / D 3 h group: very severe Tnf-α expression in the perivascular and intertubular intervals (arrowheads) (B). T 3 h / D 24 h group: severe Tnf-α expression in the perivascular and intertubular intervals (arrowheads) (C). T 3 h / D 3 h + silymarin group: medium level Tnf-α expression in the perivascular and intertubular intervals (arrowheads) (D). T 3 h / D 24 h + silymarin group: mild Tnf-α expression in the perivascular and intertubular intervals (arrowheads) (E). IHC-P, bar: 50 µm.
Figure 1 in Investigation of the effect of silymarin on oxidative DNA damage and inflammatory markers in ischemia/reperfusion injury following experimental testicular torsion/detorsion in rats
Figure 1. Testicular tissue, control group, normal histological view (A). T 3 h / D 3 h group: necrosis in spermatocytes (arrowheads); severe congestion in intertubular intervals (thick arrows); hemorrhage, thinning in the tubulus wall (B). T 3 h / D 24 h: necrosis in spermatocytes (arrowheads); severe edema in the intertubular space (stars); thinning of the tubulus wall (C). T 3 h / D 3 h + silymarin group: moderate edema in the intertubular intervals (star); congestion (thick arrow) (D). T 3 h / D 24 h + silymarin group: mild edema at intertubular intervals (star) (E); H and E, bar: 50 µm.
Figure 3 in Investigation of the effect of silymarin on oxidative DNA damage and inflammatory markers in ischemia/reperfusion injury following experimental testicular torsion/detorsion in rats
Figure 3. Testicular tissue, control group, negative 8-OHdG expression (A). T 3 h / D 3 h group: severe cytoplasmic 8-OHdG expression in spermatocytes (arrowheads) (B). T 3 h / D 24 h group: severe cytoplasmic 8-OHdG expression in spermatocytes (arrowheads) (C). T 3 h / D 3 h + silymarin group: moderate cytoplasmic 8-OHdG expression in spermatocytes (arrowheads) (D). T 3 h / D 24 h + silymarin group: mild cytoplasmic 8-OHdG expression in spermatocytes (E), IHC-P, bar: 50 µm.
Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi
ClinicalTrials.gov study NCT07058090. IPD Sharing: NO. Countries: 0. Publications: 4.
Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris
ClinicalTrials.gov study NCT04490967. IPD Sharing: YES. Countries: 0. Publications: 31.
Silymarin Cream Versus Combined Silymarin Cream and Microneedling in Treatment of Melasma
ClinicalTrials.gov study NCT05099601. IPD Sharing: UNDECIDED. Countries: 0. Publications: 13.
Global transcriptome analysis of long RNA molecules expressed in human keratinocyte cell line HaCaT pre-treated with TGF-β1 in response to silymarin, a natural plant extract involved in skin tissue re
GEO Series GSE162336. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Figure 1 from: Hamed RA, Talib WH (2024) Targeting cisplatin resistance in breast cancer using a combination of Thymoquinone and Silymarin: an in vitro and in vivo study. Pharmacia 71: 1-19. https://doi.org/10.3897/pharmacia.71.e117997
Figure 1 Shows the treatment groups for the in vivo study with the subjected doses.
Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs
ClinicalTrials.gov study NCT01436929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
ClinicalTrials.gov study NCT01091324. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
ClinicalTrials.gov study NCT00755950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery
ClinicalTrials.gov study NCT06114719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules
ClinicalTrials.gov study NCT05042245. IPD Sharing: NO. Countries: 1. Publications: 0.
Silymarin vs Hesperidin/Diosmin in Fibromyalgia
ClinicalTrials.gov study NCT07293767. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
ClinicalTrials.gov study NCT05144217. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy
ClinicalTrials.gov study NCT01258686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Silymarin Bioavailability Study
ClinicalTrials.gov study NCT06882681. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors
ClinicalTrials.gov study NCT06425705. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
ClinicalTrials.gov study NCT01018615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
ClinicalTrials.gov study NCT07001150. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.